No Detail Found!

Obesity in COVID-19 patients is a complex interaction

Author(s)
Batool Mutar Mahdi Department of Microbiology, Al-Kindy College of Medicine, University of Baghdad, Iraq
Wafaa Hazim Salih Department of Microbiology, Al-Kindy College of Medicine, University of Baghdad, Iraq
Abstract
Objective: To assess role of obesity in Covid-19 patients on antibodies production, diabetes development, and treatment of this disease. Methodology: This observational study included 200 Covid-19 patients in privet centers from January 1, 2021 to January 1, 2022. All patients had fasting blood sugars and anti-Covid-19antibodies. Anthropometric parameters were measured in all participants. Results: The patients were divided into two groups according to body weight; normal body weight (50) and excess body weight (150). There was a significant difference between them regarding age. Diabetes mellitus developed in 20% of normal weight patients while 80% of excess weight patients had diabetes (p=0.0001). Antibodies production (IgM and IgG) occurred in normal weight patients (90% and 98%, respectively). Only 4% patients with normal weight needed oxygen therapy while 93.33% of obese patients required oxygen therapy. Conclusions: Obesity increased the development of diabetes, decrease antibodies production and increase requirement for oxygen therapy in Covid-19 patients.
Publication Details
Page(s) 553-555
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 48, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Obesity, diabetes., COVID-19, Covid-19
References
Islam KU,Iqbal J .2020 .. An Update on Molecular Diagnostics for COVID-19. Front Cell Infect Microbiol, 10 : 560616.
Galib BA .2020 .SARS-CoV-2(COVID-19). J Fac Med Bagdad, 61 : 91-3.
Dawood H,Hwayyiz A,Ibrahim I,Abdul Rahman I. .2021 .The clinical features of COVID - 19 in a group of Iraqi patients: A record review. J Fac Med Bagdad, 63 : 8-12.
Mutar Mahdi B. COVID .2020 .-19 type III hypersensitivity reaction. Med Hypotheses, 109763 : 109763.
Allawi JS,Abbas HM,Rasheed JI,Sulaiman TI,Gatea AA,Al-Lami F .2020 .The first 40-days experience and clinical outcomes in the management of coronavirus covid-19 crisis. Single center preliminary study. J Fac Med Bagdad, 61 : 163-7.
Mahdi BM .2021 .9(A. Vaccine Hesitancy and Acceptance among Medical Students: An Online Crosssectional Study in Iraq. Open Access Maced J Med Sci, : 955-8.
Frydrych LM,Bian G,O'Lone DE,Ward PA,Delano MJ PA .2018 .Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol, 104 : 525-534.
Talbot HK,Coleman LA,Crimin K. .2012 .Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine, 30 : 3937-3943.
Dixon AE,Peters U. .2018 .The effect of obesity on lung function. Expert Rev Respir Med, 12 : 755-767.
Zhou Y,Chi J,Lv W,Wang Y .2021 .Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev, 10 : e3377.
Bello-Chavolla OY,Bahena-Lopez JP,Antonio-Villa NE,Vargas-Vazquez A,Gonzalez-Diaz A,MarquezSalinas A .2020 .Predicting Mortality Due to SARS-CoV2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab, 105 : 2752-61.
Liu D,Zhang T,Wang Y,Xia L Y .2021 .. The Centrality of Obesity in the Course of Severe COVID-19. Front Endocrinol (Lausanne) 2021 Mar, 620566 : 620566.
Singh AK,Khunti K. .2022 .COVID-19 and Diabetes. Annu Rev Med, 73 : 129-147.
Muscogiuri G,Pugliese G,Barrea L,Savastano S,Colao A .2020 .. for COVID-19? Metabolism, 10 : 154251.
Pietri L,Giorgi R,Bégu A .2021 .Excess body weight is an independent risk factor for severe forms of COVID-19. Metabolism, 10 : 154703.
Green WD,Beck MA .2017 .Obesity impairs the adaptive immune response to influenza virus. Ann Am Thorac Soc, 14 : S406-9.
Ponti G,Maccaferri M,Ruini C,Tomasi A,Ozben T. .2020 .Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci, 57 : 389-399.
Bivona G,Agnello L,Ciaccio M .2021 .Biomarkers for Prognosis and Treatment Response in. Patients. Ann Lab Med, 41 : 540-548.
Ma RCW,Holt RIG .2020 .COVID-19 and diabetes. Diabet Med, 37 : 723-725.
Lima-Martínez MM,Carrera Boada C,Madera-Silva MD,Marín W,Contreras M. COVID .2021 .-19 and diabetes: A bidirectional relationship. COVID-19 y diabetes mellitus: unarelaciónbidireccional. Clin Investig Arterioscler, 33 : 151-157.
López-Macías C,Rivera-Hernández T .2020 .. Antibodies and protection against COVID-19. Rev Med Inst Mex Seguro Soc, 58 : 76-77.
Watanabe M,Balena A,Tuccinardi D. .2022 .Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine. Diabetes Metab Res Rev, 10(1) : e3465.
McLarnon A .2011 .Influenza immunity impaired in obesity. Nat Rev Endocrinol, 8 : 3-8.
0

Citations

0

Downloads

44

Views